RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @garryjennings: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/E43ypsNUAa Congratulations John…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Wow. This is s big deal.
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @pepermit: Este trabajo refuerza la conclusión de que la aspirina no es para todos https://t.co/poK1OH5GJ5
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @carvicab: Un hilo de Topol comentando resultados del ASPREE. No es de utilidad tomar aspirina a bajas dosis si se es un anciano sano.…
This is surprising and great insight on why we need good research and continuation. This study hopefully will motivate researchers/clinicians to find solutions
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @Aging_Scientist: Welcome to primary prevention hell, where good theories lay down to die. I was quite looking forward to new Aspirin da…
RT @DrToddLee: Game changing and of immediate importance https://t.co/Co9YIHXMP9
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @CiaConnell: Nearly 20,000 participants and a HR of 1.01 - could we be any more certain? What a valuable trial. Goodbye aspirin!👋🏽 #Card…
RT @garryjennings: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/E43ypsNUAa Congratulations John…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @Drlipid: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher r…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @TroKalayjian: Cardiologists got screwed this week👇🏻👇🏻 ❌Effect of ASA on Mortality in Elderly https://t.co/JmNXUrOxsG ❌Effect of ASA o…
RT @NEJM: Original Article: Effect of #Aspirin on Disability-free Survival in the Healthy Elderly (ASPREE) https://t.co/QUFKIcTuPI https://…
3 ° gol en contra para la aspirina en la prevención primaria? Primero ARRIVE con 12546p de riesgo moderado, ASCEND con 15480 diabéticos, ahora ASPREE con 19 114 ancianos sanos sin beneficio con 100 mg/d AAS @ComunidadFAC @SIACardio https://t.co/N6wn
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
Congratulations to John McNeil and the ASPREE team. An amazing an important achievement
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @graffeo: Huge deal, even just from a #tbi #neurotrauma perspective https://t.co/Bce1XR5LEa
がんの再発予防としての低用量アスピリンの臨床試験も多々進行していたような…。。アスピリンの今後は如何に。
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @carvicab: El estudio incluyó más de 19 mil personas y está publicado en el New England Medical Journal , una de las revistas médicas má…
RT @AnastasiaSMihai: Congratulations @profcmreid, Dr Robyn Woods 🇦🇺& coauthors & due recognition in @NEJM 👏👏 Effect of Aspirin on Disabili…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @garryjennings: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/E43ypsNUAa Congratulations John…
Congratulations to the ASPREE team - clinical trials on an industrial scale! @JohnMcNeil6
ASPREE (Part 1): In patients over 70 years of age without CVD/dementia/disability, ASA vs. placebo for 4.7 years did not reduce disability free survival.
Interesting. Wonder if it relates to anemia in the elderly.
RT @DrNaifAlJohani: تناول حبة اسبرين لكبار السن [بدون وجود سبب مبرر لذلك كجلطة سابقة] مضرة . #اطباء_العالم #صوت_الطبيب https://t.co/fYk3…
So proud to be part of @Monash_SPHPM - what an amazing contribution to the public health evidence base! Well done @JohnMcNeil6 and team 🙌🏾👍🏾 @MonashUni #asprin #ASPREE
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Carlo V Caballero MD on Twitter https://t.co/4iXJzq2BKJ
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @carvicab: El estudio incluyó más de 19 mil personas y está publicado en el New England Medical Journal , una de las revistas médicas má…
RT @runnermandoc: Important to take into account when optimising medicines for older people: ‘Aspirin use in healthy elderly persons did no…
RT @MichaelSagnerMD: Absolutely essential findings for #preventivemedicine Is Aspirin a preventive agent? at what dosage? what side effects…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @EricWong_MD: The #ASPREE trial should no ↓ in death, dementia or disability with daily #ASA in adults age >70 for 1º prevention over me…
RT @Office_j: 【豪州、米国、高齢者19114例ランダム化、4.7年 [中央値] 観察:アスピリン100mg/日でプラセボに比べ、認知症・身体障害なしの生存HRは1.01 [95%CI 0.92-1.11]。認知症、身体障害それぞれのみで比較しても有意差なし】 N…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
【豪州、米国、高齢者19114例ランダム化、4.7年 [中央値] 観察:アスピリン100mg/日でプラセボに比べ、認知症・身体障害なしの生存HRは1.01 [95%CI 0.92-1.11]。認知症、身体障害それぞれのみで比較しても有意差なし】 NEJM https://t.co/FmrfaUIwHe
Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo. https://t.co/ocMQY974XV
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @runnermandoc: Important to take into account when optimising medicines for older people: ‘Aspirin use in healthy elderly persons did no…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
@hect2701
RT @IntraMednet: Effect of Aspirin on Disability-free Survival in the Healthy Elderly. https://t.co/b2e3T2ZeUm https://t.co/5obZUtBk3N
RT @Drlipid: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher r…
RT @thecurbsiders: 👀... "#Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Effect of Aspirin on Disability-free Survival in the Healthy Elderly. https://t.co/b2e3T2ZeUm https://t.co/5obZUtBk3N
RT @Drlipid: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher r…
RT @AnastasiaSMihai: Congratulations @profcmreid, Dr Robyn Woods 🇦🇺& coauthors & due recognition in @NEJM 👏👏 Effect of Aspirin on Disabili…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @garryjennings: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/E43ypsNUAa Congratulations John…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Congratulations @profcmreid, Dr Robyn Woods 🇦🇺& coauthors & due recognition in @NEJM 👏👏 Effect of Aspirin on Disability-free Survival in Healthy Elderly https://t.co/ag5ppQt5XJ @HBPRCA @OzCvA @thecsanz @DrMarthaGulati @ISHBP @escardio @American_He
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Huge deal, even just from a #tbi #neurotrauma perspective
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @RosenthalHealth: But good for sales! #AnAmericanSickness https://t.co/JUPyNeuRne
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @thecurbsiders: 👀... "#Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led…
RT @sophiescott2: Read our take on the #aspirin #ASPREE story here https://t.co/QQA4wIleVe https://t.co/oY8LsF6LSs